Efficacy and safety of rosuvastatin 40 mg alone or in combination with ezetimibe in patients at high risk of cardiovascular disease (results from the EXPLORER study)

CM Ballantyne, R Weiss, T Moccetti, A Vogt… - The American journal of …, 2007 - Elsevier
Patients at risk of coronary heart disease may not achieve recommended low-density
lipoprotein (LDL) cholesterol goals on statin monotherapy. This study was designed to …
被引用次数：285 相关文章

Efficacy and safety of rosuvastatin 40 mg alone or in combination with ezetimibe in patients at high risk of cardiovascular disease (results from the EXPLORER study)

CM Ballantyne, R Weiss, T Moccetti, A Vogt, B Eber… - 2007 - pubmed.ncbi.nlm.nih.gov
Patients at risk of coronary heart disease may not achieve recommended low-density
lipoprotein (LDL) cholesterol goals on statin monotherapy. This study was designed to …

Efficacy and Safety of Rosuvastatin 40 mg Alone or in Combination With Ezetimibe in Patients at High Risk of Cardiovascular Disease (Results from the EXPLORER …

CM Ballantyne, R Weiss, T Moccetti, A Vogt… - American Journal of …, 2007 - ajconline.org
Patients at risk of coronary heart disease may not achieve recommended low-density
lipoprotein (LDL) cholesterol goals on statin monotherapy. This study was designed to …

Efficacy and Safety of Rosuvastatin 40 mg Alone or in Combination With Ezetimibe in Patients at High Risk of Cardiovascular Disease (Results from the EXPLORER …

CM Ballantyne, R Weiss, T Moccetti, A Vogt… - The American Journal of …, 2007 - Elsevier
Patients at risk of coronary heart disease may not achieve recommended low-density
lipoprotein (LDL) cholesterol goals on statin monotherapy. This study was designed to …

[引用][C] Efficacy and safety of rosuvastatin 40mg alone or in combination with ezetimibe in patients at high risk of cardiovascular disease (results from the EXPLORER …

B CM - Am J Cardiol, 2007 - cir.nii.ac.jp
Efficacy and safety of rosuvastatin 40mg alone or in combination with ezetimibe in patients at
high risk of cardiovascular disease (results from the EXPLORER study) | CiNii Research CiNii …

Efficacy and safety of rosuvastatin 40 mg alone or in combination with ezetimibe in patients at high risk of cardiovascular disease (results from the EXPLORER study).

CM Ballantyne, R Weiss, T Moccetti, A Vogt… - The American Journal …, 2007 - europepmc.org
Patients at risk of coronary heart disease may not achieve recommended low-density
lipoprotein (LDL) cholesterol goals on statin monotherapy. This study was designed to …

Efficacy and Safety of Rosuvastatin 40 mg Alone or in Combination With Ezetimibe in Patients at High Risk of Cardiovascular Disease (Results from the EXPLORER …

CM Ballantyne, R Weiss, T Moccetti, A Vogt… - The American Journal of …, 2007 - infona.pl
Patients at risk of coronary heart disease may not achieve recommended low-density
lipoprotein (LDL) cholesterol goals on statin monotherapy. This study was designed to …

[引用][C] Efficacy and safety of Rosuvastatin 40 mg alone or in combination with Ezetimibe in patients at high risk of cardiovascular disease (Results from the EXPLORER …

CM BALLANTYNE, R WEISS… - … American journal of …, 2007 - pascal-francis.inist.fr
Efficacy and safety of Rosuvastatin 40 mg alone or in combination with Ezetimibe in patients at
high risk of cardiovascular disease (Results from the EXPLORER Study) CNRS Inist …

[引用][C] Efficacy and safety of rosuvastatin 40 mg alone or in combination with ezetimibe in patients at high risk of cardiovascular disease (results from the EXPLORER …

B CM - Am J Cardiol, 2007 - cir.nii.ac.jp
Efficacy and safety of rosuvastatin 40 mg alone or in combination with ezetimibe in patients at
high risk of cardiovascular disease (results from the EXPLORER study) | CiNii Research CiNii …

[引用][C] Efficacy and safety of Rosuvastatin 40 mg alone or in combination with Ezetimibe in patients at high risk of cardiovascular disease (Results from the EXPLORER …

CM BALLANTYNE, R WEISS, T MOCCETTI… - The American journal of …, 2007 - Elsevier